Biotechnology
Adaptive Biotechnologies is a biotechnology company focused on harnessing the adaptive immune system to transform disease diagnosis and treatment. The company develops proprietary immune receptor datasets and machine learning models for predicting T cell receptor (TCR) and peptide-MHC complex interactions, which have applications in both diagnostic and therapeutic initiatives. Their work combines expertise in immune biology, experimental assay development, and large-scale machine learning to enable precision medicine solutions. Adaptive is pioneering the field of immune medicine by creating tools that leverage the body's adaptive immune system to improve patient outcomes.
Beta · Sourced from candidate reports
Be the first to share your experience with Adaptive Biotechnologies.
Your reply helps other candidates know what to expect.
